Prevalence of CYP3A5 Genomic Variances and Their Impact on Tacrolimus Dosing Requirements among Kidney Transplant Recipients in Eastern North Carolina-Reference-Cited by-同舟云学术

Prevalence of CYP3A5 Genomic Variances and Their Impact on Tacrolimus Dosing Requirements among Kidney Transplant Recipients in Eastern North Carolina

Published:2017-07-27 Issue:9 Volume:37 Page:1081-1088
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Maldonado Angela Q.¹,Asempa Tomefa²,Hudson Suzanne³,Rebellato Lorita M.⁴

Affiliation:

1. Department of Transplant Surgery; Vidant Medical Center; Greenville North Carolina

2. Department of Pharmacy; Vidant Medical Center; Greenville North Carolina

3. Department of Biostatistics; East Carolina University; Greenville North Carolina

4. Department of Pathology & Laboratory Medicine; The Brody School of Medicine at East Carolina University; Greenville North Carolina

Funder

Brody Brothers Endowment, Seed/bridge grant program 2016

Publisher

Wiley

Subject

Pharmacology (medical)

Reference34 articles.

1. United States Census Bureau Quick Facts Pitt County, North Carolina 2015 http://www.census.gov/quickfacts/table/PST045215/37147

2. U.S. Department of Health and Human Services Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients https://optn.transplant.hrsa.gov/data/view-data-reports/center-data/

3. Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group;Neylan;Transplant Proc,1998

4. African American kidney transplantation survival: the ability of immunosuppression to balance the inherent pre- and post-transplant risk factors;Malat;Drugs,2009

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of donor <i>CYP3A5</i> genotype on pharmacokinetics of tacrolimus in South African paediatric liver transplant patients;South African Medical Journal;2024-04-24

2. Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy;Gynecologic Oncology;2023-01

3. Influence of CYP3A4 *22 and CYP3A5 *3 combined genotypes on tacrolimus dose requirements in Egyptian renal transplant patients;Journal of Clinical Pharmacy and Therapeutics;2022-11-15

4. The Impact of Single Nucleotide Polymorphisms on the Pharmacokinetics of Tacrolimus in Kidney Allograft Recipients of Northern- West, Iran;Advanced Pharmaceutical Bulletin;2022-01-02

5. Time within therapeutic range: A comparison of three tacrolimus formulations in renal transplant recipients;Journal of Clinical Nephrology;2022